| Literature DB >> 23917941 |
Ricardo Américo Ribeiro de Sá, Clayton Lima Melo, Raquel Batista Dantas, Luciana Valverde Vieira Delfim.
Abstract
Obtaining venous access in critically ill children is an essential procedure to restore blood volume and administer drugs during pediatric emergencies. The first option for vascular access is through a peripheral vein puncture. If this route cannot be used or if a prolonged period of access is necessary, then the intraosseous route is an effective option for rapid and safe venous access. The present work is a descriptive and exploratory literature review. The study's aim was to describe the techniques, professional responsibilities, and care related to obtaining venous access via the intraosseous route in pediatric emergencies. We selected 22 articles (published between 2000 and 2011) that were available in the Latin American and Caribbean Health Sciences (LILACS) and MEDLINE databases and the SciELO electronic library, in addition to the current protocol of cardiopulmonary resuscitation from the American Heart Association (2010). After the literature search, data were pooled and grouped into the following categories of analysis: historical aspects and physiological principles; indications, benefits, and contraindications; professional assignments; technical principles; care during the access; and possible complications. The results of the present study revealed that the intraosseous route is considered the main secondary option for vascular access during the emergency response because the technique is quick and easily executed, presents several non-collapsible puncture sites, and enables the rapid and effective administration of drugs and fluid replacement.Entities:
Year: 2012 PMID: 23917941 PMCID: PMC4031810 DOI: 10.1590/s0103-507x2012000400019
Source DB: PubMed Journal: Rev Bras Ter Intensiva ISSN: 0103-507X
Characteristic of the main access routes in pediatric patients.(
| Access route during emergency treatment | + + + + | + + | + + + | + + | + + + | + | + + |
| Ease of performing the technique | + + + + | + + | + + + | + + | + + + | + | + |
| Infection | + | + + | + + | + + | + | + | + + |
| Thrombosis | 0 | + | + + | + | + | + | + + + + |
| Other complications | + | + + | + | + | 0 | + | 0 |
| Appropriate for long-term use | 0 | + + + | + + | + + | + | + | 0 |
| Appropriate for short-term use | + + + + | + + | + + + | + + + | + + | + + + | + + |
0 - no effect/not applicable/no risk; + + + + - higher effect/most used/high risk; + - lower effect/less used/low risk.
Most important indications for intraosseous access associated with the clinical care sectors.
| Intensive care unit | Admission of patients without the possibility of peripheral vascular access; multiple organ failure; acute respiratory syndrome; acute renal or hepatic failure; bleeding that requires rapid fluid replacement; disseminated intravascular coagulation; severe hemodynamic disorders |
| Emergency service | Cardiopulmonary resuscitation; patients with difficult peripheral access that require the administration of fluids and drugs, such as polytrauma care and cardiac or respiratory failure; exogenic poisoning |
| Surgical center | Loss of peripheral access during surgery; complicated peripheral access for emergency surgery |
| Pre-hospital care | Polytrauma care; cardiopulmonary resuscitation; inability to access peripheral puncture sites in patients in shock or with severe hemodynamic disturbances |
Modified from Vizcarra C, Clum S. Intraosseous route as alternative access for infusion therapy. J Infus Nurs. 2010;33(3):162-74. Erratum in J Infus Nurs. 2011;34(2):123.(
Most commons medications for intraosseous administration.(
| Fentanyl | Amikacin | Blood Components | Atracurium | Adenosine | Antitoxins |
| Ketamine | Ampicillin | Glucose | Pancuronium | Adrenaline | Contrast |
| Lorazepam | Ceftriaxone | Ringer's Lactate Solution | Rocuronium | Atropine | Dexamethasone |
| Midazolam | Clindamycin | Isotonic and hypertonic saline | Succinylcholine | Calcium Chloride | Diazoxide |
| Morphine | Gentamicin | Vecuronium | Digoxin | Heparin | |
| Phenobarbital | Sulfadiazine | Dobutamine | Insulin | ||
| Phenytoin | Vancomycin | Dopamine | Methylene blue | ||
| Propofol | Isoproterenol | Methylprednisolone | |||
| Lidocaine | Prostaglandins | ||||
| Noradrenaline | Vitamins | ||||
| Sodium bicarbonate solution (diluted) | |||||
| Vasopressin |
Devices for intraosseous puncture.(
| Manual | Steel needle with a removable trocar to prevent plugging of the needle by bone fragments | Manual insertion in the medullary space, controlled by the operator | IO Jamshidi®
| |
| Automatic | Impact | Steel trocar needle, operated by a spring | Upon being triggered, the device automatically inserts the trocar needle into the spinal canal via spring tension. | Bone Injection Gun (BIG)® (Wais Med LTD) |
| Electric | Steel trocar needle, battery-operated power driver | Upon being triggered, the device is inserted into the medullary canal via spinning (the device resembles an orthopedic drill bit) | EZ-IO®
| |
Insertion sites and intraosseous access devices.(
| Sternum | ✓ | 0 | Manual, FAST 1® |
| Humeral head | ✓ | 0 | Manual, BIG®, EZ-IO® |
| Distal radius | ✓ | 0 | Manual |
| Distal ulna | ✓ | 0 | Manual |
| Iliac crest | ✓ | 0 | Manual |
| Distal femur | ✓ | ✓ | Manual, BIG®, EZ-IO® |
| Proximal tibia | ✓ | ✓ | Manual, BIG®, EZ-IO® |
| Distal tibia | ✓ | ✓ | Manual, BIG®, EZ-IO® |
Care during intraosseous access, along with its justifications.(
| Define the injection site and the appropriate apparatus. | There are devices specific for different puncture sites. |
| Use aseptic techniques for insertion and removal of the needle and handling apparatus. | To prevent puncture-site infection, osteomyelitis, and sepsis |
| Fix the needle, as well as the stents and catheters. | To avoid the needle being pulled out, preventing loss of access, leakage, and damage to the tissue and bone |
| Use a continuous infusion pump for fluids, drugs, and blood components. | To ensure the continuity and rate of infusion, which are not maintained by gravity. Furthermore, as in the intravenous route, the alarms of infusion pumps may indicate obstruction of the apparatus, which may suggest infiltration. |
| Inject a 10 ml bolus of physiological saline (0.9%) every 4 hours. | To prevent clogging of the device, the discontinuity of infusion, and loss of the access. |
| Verify the operation and permeability of the apparatus. | To avoid clogging of the apparatus and its consequences, such as loss of access and disruption of the infusion, which would compromise the patient's health. |
| Evaluate the presence of edema, erythema, and hypersensitivity at the puncture site after removing the needle. | To enable the early detection and treatment of complications, such as bleeding and infiltration |
| Apply an occlusive, sterile-gauze dressing to the puncture site using aseptic technique. | To prevent contamination and reduce the risk of infection at the puncture site |
| Support professional training and establish protocols for the procedure. | To increase the chances of success of the procedure, to instruct professionals regarding their responsibilities in clinically managing the access, and to provide safe and effective patient care |
Managing the major complications related to intraosseous access.(
| Extravasation | Remove the device, elevate the limb, and apply a cold compress to the puncture site |
| Osteomyelitis | Remove the device within 24 hours. Initiate antibiotic therapy (as prescribed by the physician) to treat the osteomyelitis |
| Compartment syndrome | Remove the device, elevate the limb, apply a cold compress to the puncture site, and consult the surgeon (fasciotomy and removal of necrotic tissue are required in severe cases) |
| Fat embolism | No specific treatment (no cases have been reported in the literature for pediatric patients) |